International Society for Pharmacoeconomics and Outcomes Research
Budget
€18,987,064
EP Access
0
accredited persons
Staff
13
2 FTE
EU Grants
None
Mission & Goals
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR)—is an international, multistakeholder, nonprofit organization. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the HEOR field. ISPOR is dedicated to improving healthcare decision making. We believe that every healthcare decision should be informed by the best scientific research. Toward that goal, the Society’s mission is to advance health economics and outcomes research excellence to improve decision making for health globally. Our vision is a world where healthcare is accessible, effective, efficient, and affordable for all. Our core values are Transformative, Scientific, Inclusive, Collaborative, Transparent, and Ethical.
EU Legislative Interests
Strategy for European Life Sciences Reform of the EU pharmaceutical legislation Critical Medicines Act Medical Device Regulation targeted review Biotech Act Cardiovascular health Plan EU HTA Regulation
Communication Activities
Contribute to public consultations - soliciting input from our members Convene global stakeholders to solicit insights and raise awareness on current and upcoming developments in the EU health policy landscape, bridging the gap between technology assessors, private and public payers, regulators, and patients to improve health globally eg global HTA Roundtable meetings https://www.ispor.org/member-groups/councils-roundtables/health-technology-assessment-council/health-technology-assessment-roundtables Provide platforms and education sessions for communicating progress, interim outcomes/outputs of application of legislative acts and proposals through conference sessions, webinars, and journal content. For example: ISPOR Europe 2025 https://www.ispor.org/conferences-education/conferences/upcoming-conferences/ispor-europe-2025/program/program/ and ISPOR Europe 2024 conference https://www.ispor.org/conferences-education/conferences/past-conferences/ispor-europe-2024/program/program/session/euro2024-3967/19036 Collaborate in development of patient training programs related to EU HTA regulations, partnering for example with EUPATI, and advocating for the value of patient engagement in value assessment and research. ISPOR has multiple publications - two peer-reviewed journals Value in Health and Value in Health Regional Issues, and Value and Outcomes Spotlight. https://www.ispor.org/publications/journals
Interests Represented
Does not represent commercial interests
Member Of
WHO Novel Medicines Platform https://www.who.int/europe/groups/the-novel-medicines-platform EUPATI https://eupati.eu/our-organisation/ American Society for Association Executives https://www.asaecenter.org/
Organisation Members
ISPOR—The Professional Society for Health Economics and Outcomes Research, founded in 1995 is a leading global scientific and educational organization for health economics and outcomes research with 7,100+ individual members, and 7,000+ Chapter Members. The Society has representation across 110 countries through 80+ Regional Chapters, https://www.ispor.org/member-groups/global-groups/regional-chapters, 100+ Student Chapters https://www.ispor.org/member-groups/students/student-chapters and other Member Groups https://www.ispor.org/member-groups. ISPOR is a multistakeholder association with individual members across various disciplines within the field including researchers, academicians, regulators and assessors, public and private payers, healthcare providers, industry, and patient representatives. The geographic breakdown of ISPOR's membership is 39% North America, 33% European, 21% Asia Pacific, 6% Middle East / Africa, and 2% Latin America.
Additional Information
The above reflects total revenue for 1/1/24 to 31/12/2024
Commissioner Meetings
No recorded meetings with EU commissioners.